Skip to content
★ Sign in to follow
Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh logo

Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh Stock: price and insider trades · Hong Kong

HK·Mcap HK$5.4BHealth Care

Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh: what insiders have been doing

Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh is a Health Care company. Its directors and officers file their transactions with HKEX. From 24 October 2025 to 24 October 2026, the disclosure feed for Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh logged 4 filings by 2 insiders.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Across the 1,315 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark.

Insider buying of Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh has been absent for the past year. The median gap between a trade and its publication by HKEX is 13 days. That lag is the time during which only the insider knows about the trade.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$16.18
Analyst consensus
1 analysts
·
HK$38.30Target HK$38.30(+137%)HK$38.30
Income statement
EBITDA-HK$111.3M
Net income-HK$182.5M0.0% margin
Valuation
PER (forward)-21.3x
P/Book4.8x
Balance sheet & cash
Market capHK$5.4B
Total debtHK$49.7M
Free Cash Flow-HK$154.1M
Debt / Equity0%
Profitability & ownership
% insiders53.0%
% institutions32.7%
Last declaration on 7 July 2026
Declarations4 total
  • ●
    DirectorExecutives
    0HKEX
    99,660,050 sharesShareXHKGHKEX:DA20260707E00167
  • ●
    DirectorExecutives
    0HKEX
    44,400,000 sharesShareXHKGHKEX:DA20260707E00176
  • ●
    DirectorExecutives
    0HKEX
    99,660,050 sharesShareXHKGHKEX:DA20260707E00175
  • ●
    DirectorExecutives
    0HKEX
    44,400,000 sharesShareXHKGHKEX:DA20260707E00168

4 of 4 declarations

About Shaanxi Micot Pharmaceutical Technology Co., Ltd. - B - H Sh

Shaanxi Micot Pharmaceutical Technology Co., Ltd. is a company focused on the development and manufacturing of pharmaceutical products. It is listed on the Hong Kong Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations